• Revenue Cycle Management
  • COVID-19
  • Reimbursement
  • Diabetes Awareness Month
  • Risk Management
  • Patient Retention
  • Staffing
  • Medical Economics® 100th Anniversary
  • Coding and documentation
  • Business of Endocrinology
  • Telehealth
  • Physicians Financial News
  • Cybersecurity
  • Cardiovascular Clinical Consult
  • Locum Tenens, brought to you by LocumLife®
  • Weight Management
  • Business of Women's Health
  • Practice Efficiency
  • Finance and Wealth
  • EHRs
  • Remote Patient Monitoring
  • Sponsored Webinars
  • Medical Technology
  • Billing and collections
  • Acute Pain Management
  • Exclusive Content
  • Value-based Care
  • Business of Pediatrics
  • Concierge Medicine 2.0 by Castle Connolly Private Health Partners
  • Practice Growth
  • Concierge Medicine
  • Business of Cardiology
  • Implementing the Topcon Ocular Telehealth Platform
  • Malpractice
  • Influenza
  • Sexual Health
  • Chronic Conditions
  • Technology
  • Legal and Policy
  • Money
  • Opinion
  • Vaccines
  • Practice Management
  • Patient Relations
  • Careers

Supreme Court to take up abortion drug case; socioeconomic status and heart health; a spike in premature deaths - Morning Medical Update


The top news stories in primary care today.

physician holding morning coffee: © batuhan toker - stock.adobe.com

© batuhan toker - stock.adobe.com

Anticipating 2024 ruling on mifepristone

The U.S. Supreme Court announced it would consider a case involving limits on mifepristone, the most common abortion medication in the country. It will be the first abortion case since the landmark Roe v. Wade was overturned in 2022.

Poor neighborhood, poor heart health

Got heart medicine? If you live in a disadvantaged neighborhood, probably not. A study of 6,247 patients found those who live in neighborhoods with lower socioeconomic status had less adherence to heart disease treatments.

Why are Americans dying so young?

More Americans are dying younger than they should be. It’s not just a COVID-19 hangover and it’s not front and center for government regulators or medical organizations. It seems the only ones paying attention are insurance companies.

Related Videos